Dietary Salt Exacerbates Isoproterenol-Induced Cardiomyopathy in Rats

Spontaneously hypertensive heart failure rats (SHHFs) take longer to develop compensated heart failure (HF) and congestive decompensation than common surgical models of HF. Isoproterenol (ISO) infusion can accelerate cardiomyopathy in young SHHFs, while dietary salt loading in hypertensive rats induces cardiac fibrosis, hypertrophy, and—in a minority—congestive HF. By combining ISO with dietary salt loading in young SHHFs, the authors sought a nonsurgical model that is more time- and resource-efficient than any of these factors alone. The authors hypothesized that salt loading would enhance ISO-accelerated cardiomyopathy, promoting fibrosis, hypertrophy, and biochemical characteristics of HF. SHHFs (lean male, 90d) were infused for 4 wk with ISO (2.5 mg/kg/day) or saline. After 2 wk of infusion, a 6-wk high-salt diet (4%, 6%, or 8% NaCl) was initiated. Eight percent salt increased heart weight, HF markers (plasma B-type natriuretic peptide, IL-6), lung lymphocytes, and indicators of lung injury and edema (albumin and protein) relative to control diet, while increasing urine pro-atrial natriuretic peptide relative to ISO-only. High salt also exacerbated ISO-cardiomyopathy and fibrosis. Thus, combining ISO infusion with dietary salt loading in SHHFs holds promise for a new rat HF model that may help researchers to elucidate HF mechanisms and unearth effective treatments.

[1]  D. Costa,et al.  Merits of Non-Invasive Rat Models of Left Ventricular Heart Failure , 2011, Cardiovascular Toxicology.

[2]  A. Ledbetter,et al.  Particulate matter inhalation exacerbates cardiopulmonary injury in a rat model of isoproterenol-induced cardiomyopathy , 2010, Inhalation toxicology.

[3]  D. Takeshita,et al.  Isoproterenol-induced hypertrophied rat hearts: does short-term treatment correspond to long-term treatment? , 2008, The journal of physiological sciences : JPS.

[4]  D. Su,et al.  PRESSOR AND NON‐PRESSOR EFFECTS OF SODIUM LOADING ON STROKE IN STROKE‐PRONE SPONTANEOUSLY HYPERTENSIVE RATS , 2008, Clinical and experimental pharmacology & physiology.

[5]  G. Dorn,et al.  Decompensation of cardiac hypertrophy: cellular mechanisms and novel therapeutic targets. , 2007, Physiology.

[6]  M. Jokinen,et al.  Characterization of spontaneous and chemically induced cardiac lesions in rodent model systems , 2007, Cardiovascular Toxicology.

[7]  A. Ledbetter,et al.  Neurotrophin mediation of allergic airways responses to inhaled diesel particles in mice. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[8]  E. Frohlich,et al.  Myocardial fibrosis, impaired coronary hemodynamics, and biventricular dysfunction in salt-loaded SHR. , 2006, American journal of physiology. Heart and circulatory physiology.

[9]  Claudio Passino,et al.  Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications. , 2006, American journal of physiology. Heart and circulatory physiology.

[10]  David R Buvat de Virginy Novel and potential future biomarkers for assessment of the severity and prognosis of chronic heart failure : a clinical review. , 2006, Heart failure reviews.

[11]  C. Elangbam Heart Trimming Protocol of the Laboratory Rat, Version 2, CD-ROM, Abraham Nyska, Beth Mahler, and Robert Maronpot , 2005, Toxicologic pathology.

[12]  J. Krieger,et al.  Chronic beta-adrenoceptor stimulation and cardiac hypertrophy with no induction of circulating renin. , 2005, European journal of pharmacology.

[13]  P. Lechat,et al.  Inhibition of Catecholamine-Induced Cardiac Fibrosis by an Aldosterone Antagonist , 2005, Journal of cardiovascular pharmacology.

[14]  A. Nishiyama,et al.  Cardiac oxidative stress in acute and chronic isoproterenol-infused rats. , 2005, Cardiovascular research.

[15]  H. Iwao,et al.  Additive beneficial effects of the combination of a calcium channel blocker and an angiotensin blocker on a hypertensive rat-heart failure model. , 2004, Hypertension research : official journal of the Japanese Society of Hypertension.

[16]  E. Frohlich,et al.  Cardiac structural and functional responses to salt loading in SHR. , 2004, American journal of physiology. Heart and circulatory physiology.

[17]  M. Hamon,et al.  Blockade of β1- and desensitization of β2-adrenoceptors reduce isoprenaline-induced cardiac fibrosis , 2004 .

[18]  S. de Denus,et al.  Brain natriuretic peptide in the management of heart failure: the versatile neurohormone. , 2004, Chest.

[19]  M. Hamon,et al.  Blockade of beta 1- and desensitization of beta 2-adrenoceptors reduce isoprenaline-induced cardiac fibrosis. , 2004, European journal of pharmacology.

[20]  B. Persson,et al.  Adrenergic mechanisms during hypertension induced by sucrose and/or salt in the spontaneously hypertensive rat , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[21]  M. Klapholz,et al.  Natriuretic peptides: biochemistry, physiology, and therapeutic role in heart failure. , 2003, Heart disease.

[22]  G. Norton,et al.  &bgr;-Adrenergic Activation Initiates Chamber Dilatation in Concentric Hypertrophy , 2003, Hypertension.

[23]  E. Blasi,et al.  Structural, functional, and molecular characterization of the SHHF model of heart failure. , 2002, American journal of physiology. Heart and circulatory physiology.

[24]  J. Towbin,et al.  The failing heart , 2002, Nature.

[25]  D. Schlenk,et al.  Toxic responses of the nervous system , 2001 .

[26]  B. Chandrasekar,et al.  Expression-Adrenergic Stimulation Induces Myocardial Proinflammatory Cytokine β Chronic , 2000 .

[27]  M. Donowitz,et al.  NHE2 contains subdomains in the COOH terminus for growth factor and protein kinase regulation. , 1999, American journal of physiology. Cell physiology.

[28]  H. Thai,et al.  Effects of AT1 receptor blockade after myocardial infarct on myocardial fibrosis, stiffness, and contractility. , 1999, American journal of physiology. Heart and circulatory physiology.

[29]  A. Gerdes,et al.  Gender-related differences in myocyte remodeling in progression to heart failure. , 1999, Hypertension.

[30]  R. Willette,et al.  The myocardial beta-adrenergic system in spontaneously hypertensive heart failure (SHHF) rats. , 1999, Hypertension.

[31]  C. Johnston,et al.  Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats. , 1998, Circulation.

[32]  R. Hernández-Muñoz,et al.  Sequential changes of energy metabolism and mitochondrial function in myocardial infarction induced by isoproterenol in rats: a long-term and integrative study. , 1997, Canadian journal of physiology and pharmacology.

[33]  E. Gelfand,et al.  Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. , 1997, American journal of respiratory and critical care medicine.

[34]  P. Singal,et al.  Role of oxidative stress in transition of hypertrophy to heart failure. , 1996, Journal of the American College of Cardiology.

[35]  E. Lakatta,et al.  The ageing spontaneously hypertensive rat as a model of the transition from stable compensated hypertrophy to heart failure. , 1995, European heart journal.

[36]  G. Wambach,et al.  BNP plasma levels during acute volume expansion and chronic sodium loading in normal men. , 1995, Clinical and experimental hypertension.

[37]  P. Singal,et al.  Antioxidant changes in hypertrophied and failing guinea pig hearts. , 1994, The American journal of physiology.

[38]  D. Das,et al.  Molecular adaptation of cellular defences following preconditioning of the heart by repeated ischaemia. , 1993, Cardiovascular research.

[39]  K. Weber,et al.  Pathologic hypertrophy with fibrosis: the structural basis for myocardial failure. , 1992, Blood pressure.

[40]  N. Minamino,et al.  Increased plasma brain natriuretic peptide levels in DOCA-salt hypertensive rats: relation to blood pressure and cardiac concentration. , 1990, Biochemical and biophysical research communications.

[41]  P. Baker,et al.  SHHF/Mcc-cp Rat: Model of Obesity, Non-insulin-dependent Diabetes, and Congestive Heart Failure , 1990 .

[42]  J. Mészáros,et al.  Ultrastructural and electrophysiological alterations during the development of catecholamine-induced cardiac hypertrophy and failure. , 1990, Acta biologica Hungarica.

[43]  P. Singal,et al.  Higher Antioxidative Capacity During a Chronic Stable Heart Hypertrophy , 1989, Circulation research.

[44]  M. Fujishima,et al.  Central and peripheral mechanisms of the enhanced hypertension following long-term salt loading in spontaneously hypertensive rats. , 1988, Japanese circulation journal.

[45]  M. Elam,et al.  Chronic salt loading and central adrenergic mechanisms in the spontaneously hypertensive rat. , 2009, Acta pharmacologica et toxicologica.

[46]  G. Rona Catecholamine cardiotoxicity. , 1985, Journal of molecular and cellular cardiology.

[47]  J. Milei,et al.  A routine method for diagnosis of early myocardial infarction. , 1983, International journal of cardiology.

[48]  R. Jaskot,et al.  An automated analysis of glutathione peroxidase, S-transferase, and reductase activity in animal tissue. , 1983, Journal of analytical toxicology.

[49]  S. Koletsky Pathologic findings and laboratory data in a new strain of obese hypertensive rats. , 1975, The American journal of pathology.

[50]  D. Spodick Mechanisms of Contraction of the Normal and Failing Heart , 1968 .

[51]  J. Ross,et al.  Mechanisms of Contraction of the Normal and Failing Heart , 1969, The New England journal of medicine.